BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36706924)

  • 1. Assessment of the inhibition risk of chlorophenol substances on cytochrome P450 via cocktail inhibition assays.
    Zhang H; Zhao F; Liu Y; Li Y; Liu H; Sun H
    Toxicol Appl Pharmacol; 2023 Feb; 461():116401. PubMed ID: 36706924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the inhibition of chlorophenols towards human cytochrome P450 3A4 and differences among various species.
    Liu NR; Yang K; Li WT; Pang ZH; Zhang Q; Wang JJ; Dang WX; Jia RY; Fu ZW; Li YX; Yao ZH; Fang ZZ
    Sci Total Environ; 2020 Jul; 724():138187. PubMed ID: 32408447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes.
    Qi XY; Liang SC; Ge GB; Liu Y; Dong PP; Zhang JW; Wang AX; Hou J; Zhu LL; Yang L; Tu CX
    Food Chem Toxicol; 2013 Jun; 56():392-7. PubMed ID: 23500771
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Zhang N; Liu J; Chen Z; Dou W
    Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
    [No Abstract]   [Full Text] [Related]  

  • 5. Strong and Selective Inhibitory Effects of the Biflavonoid Selamariscina A against CYP2C8 and CYP2C9 Enzyme Activities in Human Liver Microsomes.
    Park SY; Nguyen PH; Kim G; Jang SN; Lee GH; Phuc NM; Wu Z; Liu KH
    Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32290339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes.
    Lang J; Li W; Zhao J; Wang K; Chen D
    Xenobiotica; 2017 Oct; 47(10):849-855. PubMed ID: 27819189
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Li J; Wen H; Gao Z
    Xenobiotica; 2020 Feb; 50(2):231-236. PubMed ID: 31020909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An automated cocktail method for in vitro assessment of direct and time-dependent inhibition of nine major cytochrome P450 enzymes - application to establishing CYP2C8 inhibitor selectivity.
    Kahma H; Aurinsalo L; Neuvonen M; Katajamäki J; Paludetto MN; Viinamäki J; Launiainen T; Filppula AM; Tornio A; Niemi M; Backman JT
    Eur J Pharm Sci; 2021 Jul; 162():105810. PubMed ID: 33753217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibitory effects of pristimerin on human liver cytochrome P450 enzymes.
    Hao X; Yuan J; Xu Y; Wang Z; Hou J; Hu T
    Xenobiotica; 2018 Dec; 48(12):1185-1191. PubMed ID: 28385095
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Zhang J; Li C; Zhang J; Zhang F
    Xenobiotica; 2019 Oct; 49(10):1127-1132. PubMed ID: 29676195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone.
    Baldwin SJ; Clarke SE; Chenery RJ
    Br J Clin Pharmacol; 1999 Sep; 48(3):424-32. PubMed ID: 10510156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition of human cytochrome P450 by cudratricusxanthone A.
    Sim J; Choi E; Lee YM; Jeong GS; Lee S
    Food Chem Toxicol; 2015 Jul; 81():171-175. PubMed ID: 25936586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kim JH; Kwon SS; Kong TY; Cheong JC; Kim HS; In MK; Lee HS
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28287454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible inhibition of three important human liver cytochrome p450 enzymes by tiliroside.
    Sun DX; Lu JC; Fang ZZ; Zhang YY; Cao YF; Mao YX; Zhu LL; Yin J; Yang L
    Phytother Res; 2010 Nov; 24(11):1670-5. PubMed ID: 21031626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the inhibition of eight major human cytochrome P450 isozymes by a probe substrate cocktail
    Valicherla GR; Mishra A; Lenkalapelly S; Jillela B; Francis FM; Rajagopalan L; Srivastava P
    Xenobiotica; 2019 Dec; 49(12):1396-1402. PubMed ID: 30747554
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zhang X; Feng P; Gao X; Wang B; Gou C; Bian R
    Pharm Biol; 2020 Dec; 58(1):247-252. PubMed ID: 32223485
    [No Abstract]   [Full Text] [Related]  

  • 17.
    Li Y; Qin J; Wu H; Xu Y; Zhang L; Su K; Cui Y; Wang H
    Pharm Biol; 2020 Dec; 58(1):695-700. PubMed ID: 32673137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of catalpol on the activity of human liver cytochrome P450 enzymes.
    Liu L; Cao X; Li T; Li X
    Xenobiotica; 2019 Nov; 49(11):1289-1295. PubMed ID: 30557096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes.
    Dong G; Zhou Y; Song X
    Pharm Biol; 2018 Dec; 56(1):620-625. PubMed ID: 31070542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZY12201, A Potent TGR5 Agonist: Identification of a Novel Pan CYP450 Inhibitor Tool Compound for In-Vitro Assessment.
    Giri P; Gupta L; Rathod A; Joshi V; Giri S; Patel N; Agarwal S; R Jain M
    Drug Metab Lett; 2022 Mar; ():. PubMed ID: 35293300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.